Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 09/10/24
Vera Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial ResultsGlobeNewsWire • 08/08/24
Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceGlobeNewsWire • 06/07/24
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)GlobeNewsWire • 05/28/24
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association CongressGlobeNewsWire • 05/25/24
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial ResultsGlobeNewsWire • 05/09/24
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewsWire • 03/20/24
Vera Therapeutics to Participate at the 44th Annual TD Cowen Health Care ConferenceGlobeNewsWire • 02/28/24
Vera Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceGlobeNewsWire • 02/02/24
Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares in Public Offering of Class A Common StockGlobeNewsWire • 02/01/24
Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common StockGlobeNewsWire • 01/30/24
Vera Therapeutics Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b ORIGIN Clinical Trial OLE in IgA NephropathyGlobeNewsWire • 01/25/24
Vera Therapeutics Announces Appointment of Industry Veterans Robert Brenner, M.D. as Chief Medical Officer and William D.GlobeNewsWire • 01/08/24
Vera Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 12/27/23
This Promising Small-Cap Biotech Stock Could Rise 70%, According to Wall StreetThe Motley Fool • 12/15/23
Wall Street Analysts Believe Vera Therapeutics, Inc. (VERA) Could Rally 86.76%: Here's is How to TradeZacks Investment Research • 11/14/23
Vera Therapeutics Provides Business Update and Reports Third Quarter Financial ResultsGlobeNewsWire • 11/09/23